In terms of tumor biology, 57.89 % of the tumors were hormone receptor-positive, 23.68 % were HER2-positive, nearly half belonged to the Luminal B subtype, and 28.95 % exhibited a basal-like phenotype. Here, ERBB2 is linked to neoplasm.